AROW vs SFST

AROW's Piotroski F-Score of 3/9 indicates weak financial health, signaling potential distress in operational efficiency and capital structure. The absence of an Altman Z-Score raises concern about bankruptcy risk, especially given the lack of available debt and liquidity metrics. Despite strong profitability (27.76% margin) and explosive earnings growth (216.5% YoY), the stock trades at a premium to its Graham Number ($39.57) and intrinsic value ($78.17), suggesting overvaluation relative to conservative valuation models. The technical trend is bearish, and insider activity is neutral, with no recent trades. Analyst consensus is a hold, reflecting cautious sentiment.

SFST presents a conflicting profile characterized by a weak Piotroski F-Score of 2/9, indicating significant deterioration in fundamental financial health. Despite this, the stock appears undervalued, trading at $56.68, which is below both its Graham Number ($65.59) and its growth-based Intrinsic Value ($125.67). While YoY earnings growth is exceptionally strong at 83.10%, this is offset by bearish insider selling and a very weak technical trend (10/100). The company is currently a high-growth value play with concerning underlying health metrics.